Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression

Annals of Oncology : Official Journal of the European Society for Medical Oncology
S MontotoE Montserrat

Abstract

Different prognostic scores have been proposed to predict the outcome of follicular lymphoma (FL) patients at diagnosis. A new prognostic index specifically addressing FL patients, the Follicular Lymphoma International Prognostic Index (FLIPI), has recently been developed, which might also be useful in patients with progression. One hundred and three patients (55 male, 48 female; median age 59 years) with FL in first relapse/progression after an initial response to therapy (50 complete responders/ 53 partial responders) were included in the study. Five-year survival from progression (SFP) was 55% (95% confidence interval 44%-66%). The distribution according to the FLIPI at relapse was 39% good prognosis, 24% intermediate prognosis and 37% poor prognosis. Five-year SFP for these groups were 85%, 79% and 28%, respectively (P < 0.0001). Other variables at relapse with prognostic significance for SFP were age, presence of B symptoms, performance status, bulky disease, number of involved nodal sites, lactate dehydrogenase level, hemoglobin level, histological transformation, the Italian Lymphoma Intergroup prognostic index for FL and the International Prognostic Index for aggressive lymphomas. In the multivariate analysis bulky dise...Continue Reading

References

Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P SoubeyranB Hoerni
May 15, 1991·Annals of Internal Medicine·P LitamW S Velasquez
Dec 6, 1984·The New England Journal of Medicine·S J Horning, S A Rosenberg
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
May 9, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C HosingI F Khouri
Jun 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S MontotoE Montserrat
May 6, 2004·Blood·Philippe Solal-CélignyEmili Montserrat

❮ Previous
Next ❯

Citations

Jun 23, 2007·Annals of Hematology·Aylin Fidan KorcumGulgun Erdogan
Aug 19, 2006·Current Treatment Options in Oncology·Philippe Solal-Celigny
Aug 12, 2006·Current Oncology Reports·Andrew J Davies
Jun 25, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S A M van de SchansD J van Spronsen
Feb 9, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B MetznerC H Köhne
Sep 21, 2006·Journal of the National Cancer Institute·Susana InogèsUNKNOWN Programa para el Estudio y Tratamiento de Hemopatias Malignas study group
Apr 23, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Guillaume CartronJean-Francois Rossi
Aug 2, 2011·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Vit ProchazkaKarel Indrak
Jun 11, 2011·Best Practice & Research. Clinical Haematology·Marinus H J van Oers, Marie José Kersten
Jun 1, 2010·International Journal of Radiation Oncology, Biology, Physics·Michael J BurdickRoger Macklis
Jan 4, 2012·British Journal of Haematology·Christopher McNamaraUNKNOWN British Society for Haematology Committee
Sep 19, 2006·International Journal of Radiation Oncology, Biology, Physics·Roger M Macklis
Mar 24, 2005·Seminars in Oncology·Valerie Lewington
Aug 23, 2005·International Journal of Radiation Oncology, Biology, Physics·Abhay S GokhaleRoger M Macklis
Dec 27, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Julie M VoseJames O Armitage
Jan 18, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Laurie H SehnGinna G Laport
Oct 23, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Shivani SrivastavaSherif S Farag
Jan 27, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Claudio G BrunsteinJohn E Wagner
Feb 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joaquim CarrerasElias Campo
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas RelanderRandy D Gascoyne
Jun 25, 2020·British Journal of Haematology·Christopher McNamaraPam McKay
Jan 29, 2016·World Journal of Gastroenterology : WJG·Masaya IwamuroHiroyuki Okada
May 13, 2018·Annals of Hematology·Marc Sorigue, Juan-Manuel Sancho
Oct 17, 2017·Annals of Hematology·Marc Sorigue, Juan-Manuel Sancho
Jun 27, 2020·Hematology/oncology Clinics of North America·Ciara L Freeman, Laurie H Sehn
Jul 1, 2021·Blood Reviews·Pablo MozasArmando López-Guillermo
Apr 22, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C CasuloC R Flowers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.